Area of research
Agronomy and Crop Science · Cardiology and Cardiovascular Medicine
Research interest
The CardioMEMS is a recent FDA-approved device that is comprised of a dime-sized sensor that is placed (permanently) in a distal pulmonary artery (PA) branch. This device connects remotely (via a special electronic system in the shape of a pillow, that is given to the patient) and generates PA pressure waveforms that can be accessed via a web-based portal by the patient’s cardiology providers. This device is innovative as it allows instantaneous hemodynamic monitoring in our HF patients, often our most difficult patients to treat at BMC. It enables a precise hemodynamic information to detect volume overload 2-4 weeks prior to weight gain and initiation of symptoms and once placed, obviates any need for right heart catheterizations. The CardioMEMS has been shown in randomized-controlled trials to decrease HF hospitalizations. Early identification of volume overload enables the treating clinicians to escalate therapies and diuretics in the outpatient setting and prevents HF hospitalizations. It is placed as an outpatient or an inpatient procedure, with a minimal risk to our patients. Lastly, this device has a variety of clinical conditions that it can be applied: all HF patient with recent admission (both HFpEF and HFrEF), hemodialysis patients to help guide ultrafiltration goals, and individuals with mixed cardiac and pulmonary disease with narrow therapeutic windows of fluid management. This device is placed by Dr. Ayalon in the catheterization lab. The remote monitoring platform is established within the Cardiology clinic and is led by the Cardiomyopathy/HF NPs, with the support of the Cardiology clinic nurses, and the HF attendings. This program provides the Cardiomyopathy/HF NPs with an enhanced toolset to manage our most challenging patients, in a completely remote fashion, with high fidelity and accuracy in their home on a day-to-day manner. This program has already shown a significant reduction in HF hospitalization among the treated patients at BMC. All patie
Li B, Gershengorn HB, Vail EA, Wunsch H, Walkey AJ, Law AC, Ko D, Ayalon N, Kearney CM, Bosch NA. Inotrope selection in mixed cardiogenic shock with sepsis: a comparative analysis between milrinone and dobutamine. Ann Am Thorac Soc. 2026 Feb 01; 23(2):252-260. View Related Profiles . Walkey, Allan L
— 2026cited by 0position: selected
Paul LD, Moinul S, Urina-Jassir M, Gopal DM, Ayalon N. Expanding pulmonary artery pressure monitoring to racially and socially diverse populations: A pilot CardioMEMS program. Am J Med Sci. 2024 Oct; 368(4):408-410. View Related Profiles . Gopal, Deepa Paul, Ludwine Ayalon, Nir
— 2024cited by 0position: selected
Chugh PV, Danford J, Farber A, Ayalon N, Verma A, Helm RH, Monahan KM, Kalish JA. Retrieval of Embolized WATCHMAN® Flex Atrial Appendage Occlusion Device. Vasc Endovascular Surg. 2024 Oct; 58(7):752-756. View Related Profiles . Farber, Alik Verma, Ashish Kalish, Jeffrey Monahan, Kevin Ayalon, Nir Ch
— 2024cited by 0position: selected
Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study
Systematic dissection, preservation, and multiomics in whole human and bovine hearts.
Ayalon N, Jacobs AK. Enhancing Regional ST-Segment-Elevation Myocardial Infarction Care: A Shock to the System. Circ Cardiovasc Interv. 2023 Jun; 16(6):e013177. View Related Profiles . Jacobs, Alice Ayalon, Nir
— 2023cited by 0position: selected
Ho JE, Rahban Y, Sandhu H, Hiremath PG, Ayalon N, Qin F, Perez AJ, Downing J, Gopal DM, Cheng S, Colucci WS. Preclinical Alterations in Myocardial Microstructure in People with Metabolic Syndrome. Obesity (Silver Spring). 2017 Sep; 25(9):1516-1522. View Related Profiles . Gopal, Deepa Qin, Fuzhong D
— 2017cited by 0position: selected
Ayalon N, Jacobs AK. Incomplete Revascularization in Patients Treated With Percutaneous Coronary Intervention: When Enough Is Enough. JACC Cardiovasc Interv. 2016 Feb 8; 9(3):216-8. View Related Profiles . Jacobs, Alice Ayalon, Nir
— 2016cited by 0position: selected
Impaired Right Ventricular Hemodynamics Indicate Preclinical Pulmonary Hypertension in Patients With Metabolic Syndrome
Wang YC, Liang CS, Gopal DM, Ayalon N, Donohue C, Santhanakrishnan R, Sandhu H, Perez AJ, Downing J, Gokce N, Colucci WS, Ho JE. Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals. Circ Heart Fail. 2015 Sep; 8(5):897-904. View Related Profiles .
— 2015cited by 0position: selected
Gopal DM, Santhanakrishnan R, Wang YC, Ayalon N, Donohue C, Rahban Y, Perez AJ, Downing J, Liang CS, Gokce N, Colucci WS, Ho JE. Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome. J Am Heart Assoc. 2015 Mar; 4(3):e001597. View Rel
— 2015cited by 0position: selected
Preclinical Left Ventricular Diastolic Dysfunction in Metabolic Syndrome
Ayalon N, Gopal DM, Mooney DM, Simonetti JS, Grossman JR, Dwivedi A, Donohue C, Perez AJ, Downing J, Gokce N, Miller EJ, Liang CS, Apovian CM, Colucci WS, Ho JE. Preclinical left ventricular diastolic dysfunction in metabolic syndrome. Am J Cardiol. 2014 Sep 15; 114(6):838-42. View Related Profiles
— 2014cited by 0position: selected
Ayalon N, Flore LA, Christensen TG, Sam F. Mitochondrial encoded NADH dehydrogenase 5 (MT-ND5) gene point mutation presents as late onset cardiomyopathy. Int J Cardiol. 2013 Sep 1; 167(5):e143-5. View Related Profiles . Sam, Flora Ayalon, Nir Christensen, Thomas
— 2013cited by 0position: selected
Relationship of Plasma Galectin‐3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure
Wiznitzer A, Ayalon N, Hershkovitz R, Khamaisi M, Reece EA, Trischler H, Bashan N. Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol. 1999 Jan; 180(1 Pt 1):188-93. PMID: 9914602
— 1999cited by 0position: selected